Sorafenib tosylateProduct ingredient for Sorafenib

Name
Sorafenib tosylate
Drug Entry
Sorafenib

Sorafenib is a bi-aryl urea and an oral multikinase inhibitor. It targets cell surface tyrosine kinase receptors and downstream intracellular kinases that are implicated in tumour cell proliferation and tumour angiogenesis.1 First approved by the FDA and European Commission in 2007 for the treatment of hepatocellular carcinoma, sorafenib is also indicated to treat renal carcinoma and differentiated thyroid carcinoma.3

Accession Number
DBSALT000165
Structure
Synonyms
Sorafenib tosilate / Sorafenib tosylate
External IDs
BAY 54-9085
UNII
5T62Q3B36J
CAS Number
475207-59-1
Weight
Average: 637.027
Monoisotopic: 636.105717532
Chemical Formula
C28H24ClF3N4O6S
InChI Key
IVDHYUQIDRJSTI-UHFFFAOYSA-N
InChI
InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)
IUPAC Name
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]-C-hydroxycarbonimidoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzene-1-sulfonic acid
SMILES
CC1=CC=C(C=C1)S(O)(=O)=O.CNC(=O)C1=NC=CC(OC2=CC=C(NC(O)=NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
Human Metabolome Database
HMDB0062345
PubChem Compound
406563
ChemSpider
359744
ChEBI
50928
ChEMBL
CHEMBL1200485
Wikipedia
Sorafenib
Predicted Properties
PropertyValueSource
Water Solubility0.00152 mg/mLALOGPS
logP4.54ALOGPS
logP3.96Chemaxon
logS-5.5ALOGPS
pKa (Strongest Acidic)-7.2Chemaxon
pKa (Strongest Basic)15.04Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area95.84 Å2Chemaxon
Rotatable Bond Count7Chemaxon
Refractivity115.27 m3·mol-1Chemaxon
Polarizability42.13 Å3Chemaxon
Number of Rings4Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon